New Oxford Trial to Gather More Data on Side Effects, Benefits of anti-Covid Pill Molnupiravir: Expert

ICMR chief Dr Balram Bhargava on January 5 raised doubts on the safety profile of the oral drug and restricted it from becoming part of the country's Covid-19 treatment protocol.

from Top India News- News18.com https://ift.tt/3I15PXv

Comments

Search This Blog

Comments

3/recent-comments
Sora Cart

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla elementum viverra pharetra. Nulla facilisis, sapien non pharetra venenatis, tortor erat tempus est, sed accumsan odio ante ac elit./p>